A Call for Randomized Controlled Trials to Test the Efficacy of Chloroquine and Hydroxychloroquine as Therapeutics against Novel Coronavirus Disease (COVID-19)
- PMID: 32247318
- PMCID: PMC7204586
- DOI: 10.4269/ajtmh.20-0230
A Call for Randomized Controlled Trials to Test the Efficacy of Chloroquine and Hydroxychloroquine as Therapeutics against Novel Coronavirus Disease (COVID-19)
References
- 
    - De Lamballerie X, Boisson V, Reynier JC, Enault S, Charrel RN, Flahault A, Roques P, Le Grand R, 2008. On chikungunya acute infection and chloroquine treatment. Vector Borne Zoonotic Dis 8: 837–839. - PubMed
 
- 
    - Paton NI, Lee L, Xu Y, Ooi EE, Cheung YB, Archuleta S, Wong G, Wilder-Smith A, 2011. Chloroquine for influenza prevention: a randomized, double-blind, placebo controlled trial. Lancet Infect Dis 11: 677–683. - PubMed
 
MeSH terms
Substances
LinkOut - more resources
- Full Text Sources
- Miscellaneous
 
        